2021
DOI: 10.2482/haigan.61.423
|View full text |Cite
|
Sign up to set email alerts
|

A Case of Advanced Non-small Cell Lung Cancer with Visual Impairment due to Dural Metastasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(4 citation statements)
references
References 10 publications
0
4
0
Order By: Relevance
“…Intracranial dural metastases are rare, accounting for approximately 5% of all metastatic brain tumors. 2 , 3 ) In a systematic review of 227 cases of ocular or orbital region metastases, the incidence of metastases to the optic nerve or optic sheath was 1.3%. 4 ) Thus, no treatment strategy has been established for such metastases.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Intracranial dural metastases are rare, accounting for approximately 5% of all metastatic brain tumors. 2 , 3 ) In a systematic review of 227 cases of ocular or orbital region metastases, the incidence of metastases to the optic nerve or optic sheath was 1.3%. 4 ) Thus, no treatment strategy has been established for such metastases.…”
Section: Discussionmentioning
confidence: 99%
“… 1 ) In the third case, the metastasized tumor was located on the dura near the anterior clinoid process; the tumor was subjected to radiotherapy and treated with osimertinib (80 mg/day), an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. 2 ) Recently, osimertinib has emerged as a promising treatment alternative for patients with nonsmall cell lung cancer with EGFR mutation, an oncogenic driver of this disease. This is attributed to its ability to effectively penetrate the blood-brain barrier, making it a viable treatment option for intracranial tumors.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations